Italy OKs first large-scale unit for making radiolabelled peptides
December 20, 2010Manufacturing and Production AIFA, Advanced Accelerator Applications, BioSynthema, Italy
The world’s first industrial-scale manufacturing facility for radiolabelled peptides used in nuclear medicine has been approved by the Italian Pharmaceutical …
Sanofi signs new oncology research deals
December 20, 2010Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
Aesica aims to double capacity and turnover with UCB plants
December 20, 2010Manufacturing and Production Aesica, UCB, pharma manufacturing
UK contract manufacturer and ingredient supplier Aesica Pharmaceuticals is planning to double its production capacity with the acquisition of three …
CME Spotlight: Uniting European CME
December 20, 2010Medical Communications CME, Continuing medical education, Eugene Pozniak
I started writing this month’s column while still in Berlin, one of my favourite cities in Europe, and also the …
Refreshed Wellbeing appoints new creative director
December 17, 2010Medical Communications George Teague, Refreshed Wellbeing, appointment, medical communications
Reigate, UK-based healthcare comms agency Refreshed Wellbeing has appointed George Teague as creative director. His appointment comes at a time …
Sanofi and Merck Serono to collaborate in oncology
December 17, 2010Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis
Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
Pharma careers options – management in China
December 17, 2010Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment
Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
New hepatitis C drug offers cure for more patients
December 17, 2010Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
Chime launches new healthcare comms venture
December 17, 2010Medical Communications Chime Communications, David Rowley, Sandy Royden, healthcare comms agency, medical communications
Communications giant Chime is putting money into a new healthcare PR venture which will be run by the ex-global head …
Government consults on UK value-based pricing
December 17, 2010Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing
The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …
Merck KGaA appoints new head of pharma
December 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing
Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Government pushes on with major NHS reforms
December 16, 2010GP consortia, Health and Wellbeing Boards, NHS, NHS Commissioning Board, NHS Operating Framework, NHS reforms, PCTs
The government has set out a roadmap for its wide-ranging NHS reform plans that promises no let up in the …
Reforms are a ‘risky business’ for the NHS
December 16, 2010Civitas, GP commissioning, NHS, NHS reforms, PCTs
The government is taking a ‘big risk’ with NHS reforms that will hand GPs responsibility for commissioning services, according to …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Race on to find new Johnson & Johnson leader
December 16, 2010Sales and Marketing Johnson & Johnson, recruitment
Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …
Digital Pharma: Doing good in healthcare
December 15, 2010Medical Communications Digital Pharma blog, Dose of Digital, Healthy Thinkers, corporate responsibility
A new online community has been launched to bring together suggestions for improving healthcare and the altruistic side of those …
Novartis becomes global eye health leader as Alcon deal finalised
December 15, 2010Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Patient deaths halt Lilly cancer trial
December 15, 2010Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam
Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D
December 15, 2010Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Publicis makes German digital healthcare acquisition
December 15, 2010Medical Communications Digital District, Publicis Groupe, Publicis Healthware International, healthcare communications agency, medical communications, publicis
The healthcare arm of French communications giant Publicis Groupe has bought a German agency specialising in digital health comms to …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
